OpenAlex
PricingAboutJobs
Log inGet started
Work

Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once‐weekly, human GLP‐1 analogue, after single‐dose administration in patients with Type 2 diabetes

HTML

Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetic Medicine
DOI: 10.1111/j.1464-5491.2009.02854.x
Authors: C. Kapitza, T. Heise, P. Birman, K. Jallet, J. Ramis, R. Balena
Institutions: Profil Institute for Metabolic Research, Ipsen (France), Ipsen (Spain), F. Hoffmann-La Roche AG
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: GLP-1 receptor agonists, type 2 diabetes, pharmacokinetics, pharmacodynamics, glycemic control, postprandial blood glucose, blood glucose, safety and tolerability, gastrointestinal adverse effects, subcutaneous administration
SDG: Good health and well-being

Open Access status: closed

Funder: Ipsen
OpenAlex ID: W1984737165
FWCI: 2.886
Cites: 18
Cited by: 33
Related to: 7
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security